SomnoMed (SOM)

Shares / Stock Code

SOM

Stock Exchange / Sharemarket

Australian Securities Exchange

SomnoMed (SOM) focuses on the development and commercialisation of treatments for people who suffer from snoring and obstructive sleep apnea (OSA). The company makes a custom-made splint, which is similar to a mouth guard, that the sufferer wears while sleeping.

SOM was listed on the Australian stock market (ASX) in August 2004 and has completed its dental laboratory in Crows Nest, Sydney as of December 2004. SOM has been granted approval by the Food and Drug Administration to sell its snoring and sleep apnoea product in the US. Its subsidiaries include Amelia Blue Pty Limited, SomnoMed Inc., SomnoDent Pty Limited, SomnoMed Pte Ltd, SomnoDent AG and Somnomed Corporation Japan. Its associated company is SMH Biomaterial AG.

Customers are mainly the general public who suffer from sleep disorders. SOM's products would be sold to pharmacists, GPs, health specialists and public and private hospitals. Competitors are mainly companies in the dental and sleep medicine fields that offer generic products as well as R&D analysis to the market, both locally and overseas.

With 30,000 patients under SomnoDent therapy worldwide company have now expanded their product portfolio to include the addition of SomBrux, a customizable occlusal splint for the treatment of sleep related bruxism. SomBrux utilizes SomnoMed’s exclusive SMH BFlex material and complies with the unmatched quality synonymous with all SomnoMed products. SomBrux is a demand driven natural evolution of their dental sleep appliance range.

While company manufacture potentially life changing devices, it is via the multidisciplinary network of health care professionals including dentists, Sleep Specialists and Ear Nose and Throat Surgeons that ensures patients under SomnoMed device therapy are treated thoroughly, and in line with their evidence-based approach. Through these values company's aim to provide reliable support to patients, dentists and referring specialists in their shared quest to alleviate the strain of sleep disorders on the community.

SomnoMed (SOM) Products and Services

  • Development, manufacturing and marketing of innovative dental and medical products, with a focus on sleep-disordered breathing.

SomnoMed (SOM) Locations and Subsidiaries

SomnoMed Head Office
Level 3, 20 Clarke Street, CROWS NEST,
NSW, AUSTRALIA, 2065
Phone: (02) 94670 400
Fax: (02) 9467 0467

SomnoMed (SOM) Share Price

Submitted by ASX Listed Company on 31 May, 2010 - 17:04

Download our FREE App


Signup for Free
Don't miss out on your free share trading articles.


Free Risk Money Management Calculator for those who sign up!